Streetbeat News

Corporate Responsibility

QURE

UniQure N.V. (NASDAQ:QURE) plans to cut 20% of its workforce, or about 114 jobs, and discontinue more than half of its research and technology projects, including AMT-210 for Parkinson's disease. The restructuring is expected to generate savings of about $180 million over the next three years. The company will consolidate all manufacturing into its Lexington, MA facility and consolidate process and analytical development into its Amsterdam, Netherlands facility. Chief Scientific Officer Ricardo Dolmetsch will leave the company as part of the restructuring.

Portfolio Pulse from Vandana Singh

October 05, 2023 | 2:23 pm

EHAB

AREX Capital Management, a beneficial owner of approximately 2.4 million shares of Enhabit, Inc., has issued a letter to the company's board expressing dissatisfaction with the company's communication and execution. AREX emphasized that Enhabit should not remain a standalone public company and that a sale of the company is the only acceptable outcome. AREX warned that it will act decisively to protect its rights if a sale is not announced by early next year.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 2:10 pm

NI

NiSource Inc. (NYSE:NI) has launched a multi-phase hydrogen blending project, one of the first in the US, to mix hydrogen and natural gas at precise levels to determine optimal blend percentages and their environmental and consumer benefits. The project is part of NiSource's Future of Energy strategy, which includes a range of clean energy solutions. The company will continue to evaluate the viability of hydrogen-natural gas blends for other applications such as factories and power plants.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 2:03 pm

BA

Masdar, a renewable energy company, and Boeing (BA) have partnered to accelerate the sustainable aviation fuel industry in the UAE and globally. The partnership aims to reduce carbon emissions and promote sustainable practices in the aviation industry.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 1:13 pm

LVMHF

LVMUY

NVO

Novo Nordisk's weight-loss treatment, Wegovy, has brought substantial economic benefits to Denmark, leading to a revision of the country's annual economic growth forecast. The company's success has also boosted Denmark's reputation as a hub for scientific innovation. However, concerns are rising about the Danish economy's dependence on a single company. Novo Nordisk's shares are up 0.20% in premarket trading.

Portfolio Pulse from Vandana Singh

October 05, 2023 | 1:01 pm

COSM

Cosmos Health Inc. (NASDAQ:COSM) CEO Greg Siokas has issued a letter to shareholders outlining the company's strategic plans and financial outlook. The company has introduced its 2026 guidance, expecting to achieve over $180M in gross annual revenue and EBITDA in excess of $20M. The company has completed three acquisitions in 2023 and is making progress in R&D. The company is also considering spinning off its R&D division into a standalone, publicly listed biotech company. The CEO has invested more than $15M since inception, including almost $1M YTD.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:43 pm

HOTH

Hoth Therapeutics has filed articles of incorporation with the State of Nevada for the formation of a new wholly-owned subsidiary, Merveille.ai, on October 4.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:18 pm

AMZN

META

SPOT

Amazon has decided to discontinue Amp, its live-audio app introduced in March 2022. This decision is part of a broader pattern of project terminations at Amazon under CEO Andy Jassy's leadership. The company plans to use the insights gained from the app to enhance fan experiences on Amazon Music. Other companies, including Meta Platforms and Spotify Technology, have also rolled out live audio features.

Portfolio Pulse from Anusuya Lahiri

October 05, 2023 | 12:17 pm

QURE

uniQure has announced plans to discontinue investments in over half of its research and technology projects. Additionally, the company's Chief Scientific Officer, Ricardo Dolmetsch, will be leaving the company.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:12 am

QURE

uniQure has announced a strategic reorganization plan aimed at reducing operating expenses and supporting the advancement of multiple clinical-stage programs. The company did not provide specific details about the reorganization.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:09 am